Spontaneous reporting program facts counsel that the potential risk of dependence and its severity appear to be higher in people treated with doses greater than four mg/day and for extensive intervals (more than 12 weeks). However, in a controlled postmarketing discontinuation examine of worry disorder clients who gained XANAX, the duration of cure